Stocks and Investing
Stocks and Investing
Tue, September 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joon Lee Reiterated (ADVM) at Strong Buy and Held Target at $60 on, Sep 5th, 2023
Joon Lee of Truist Securities, Reiterated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $60 on, Sep 5th, 2023.
Joon has made no other calls on ADVM in the last 4 months.
There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Joon's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joon
- Daniil Gataulin of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $40 on, Friday, August 11th, 2023
Contributing Sources